March 2021

Boston Scientific Corp. Acquires Preventice Solutions in Deal Worth up to $1.2B

United States - Massachusetts

Boston Scientific Corp. acquired Preventice Solutions Inc., a privately held company that offers a full portfolio of mobile cardiac health solutions and services ranging from ambulatory cardiac monitors — including short- and long-term Holter monitors — to cardiac event monitors and mobile cardiac telemetry. Faegre Drinker advised Boston Scientific in the transaction, which consisted of an upfront cash payment of $925 million, and up to an additional $300 million in a potential commercial milestone payment.

The firm provided multidisciplinary counsel for the matter, with support from professionals in the corporate, labor and employment, health care, FDA-regulated products, privacy, cybersecurity and data strategy, intellectual property, benefits and executive compensation, tax, litigation, M&A insurance and real estate practice groups.

Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 40 years, the company advances science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care.

The Faegre Drinker Biddle & Reath LLP website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Drinker Biddle & Reath LLP's cookies information for more details.